Anti-inflammatory use during surgery could improve cancer outcomes
The world’s first clinical trial (SURGUVANT) evaluating anti-inflammatory use at the time of surgery in colon cancer patients to improve
Read more
The world’s first clinical trial (SURGUVANT) evaluating anti-inflammatory use at the time of surgery in colon cancer patients to improve
Read moreThe rarity of appendix cancer, accounting for less than 1 percent of tumors that originate in the gastrointestinal tract, and
Read moreA new study published in the Journal of the National Cancer Institute has identified specific genes associated with increased risk
Read moreWhen Joan Jorgensen was an undergraduate at the University of Wisconsin-Madison, her roommate confided that she had just one period
Read moreA drug used to treat altitude sickness — as well as glaucoma, epilepsy, heart failure and seizures — may also
Read moreDamage to DNA is a daily occurrence but one that human cells have evolved to manage. Now, in a new
Read moreResearchers have discovered a new kind of small-cell lung cancer (SCLC). The discovery paves the way for developing personalized medicine
Read more